Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - Aspira Women's Health Inc. | vrml-20191231xex31_2.htm |
| EX-31.1 - EX-31.1 - Aspira Women's Health Inc. | vrml-20191231xex31_1.htm |
| EX-23.1 - EX-23.1 - Aspira Women's Health Inc. | vrml-20191231xex23_1.htm |
| EX-21.0 - EX-21.0 - Aspira Women's Health Inc. | vrml-20191231xex21_0.htm |
| EX-10.22 - EX-10.22 - Aspira Women's Health Inc. | vrml-20191231xex10_22.htm |
| EX-4.5 - EX-4.5 - Aspira Women's Health Inc. | vrml-20191231xex4_5.htm |
| EX-4.4 - EX-4.4 - Aspira Women's Health Inc. | vrml-20191231xex4_4.htm |
| EX-4.10 - EX-4.10 - Aspira Women's Health Inc. | vrml-20191231xex4_10.htm |
| 10-K - 10-K - Aspira Women's Health Inc. | vrml-20191231x10k.htm |
Certification
Pursuant to 18 U.S.C. Section 1350,
as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
with Respect to the Annual Report on Form 10-K
for the Year Ended December 31, 2019
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, Chapter 63 of Title 18, United States Code), each of the undersigned officers of Vermillion, Inc., a Delaware corporation (the “Company”), does hereby certify, to the best of such officer’s knowledge, that:
|
1. |
The Company’s annual report on Form 10-K for the year ended December 31, 2019, (the “Form 10-K”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”); and |
|
2. |
The information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
Date: April 7, 2020 |
/s/ Valerie B. Palmieri |
|
|
Valerie B. Palmieri President and Chief Executive Officer (Principal Executive Officer) |
|
Date: April 7, 2020 |
/s/ Robert Beechey |
|
|
Robert Beechey Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |
The certification set forth above is being furnished as an Exhibit solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and is not being filed as part of the Form 10-K or as a separate disclosure document of the Company or the certifying officers.